DE602004016373D1 - NEUE INHIBITOREN DER 17beta HYDROXYSTEROID-DEHYDROGENASE TYP I - Google Patents

NEUE INHIBITOREN DER 17beta HYDROXYSTEROID-DEHYDROGENASE TYP I

Info

Publication number
DE602004016373D1
DE602004016373D1 DE602004016373T DE602004016373T DE602004016373D1 DE 602004016373 D1 DE602004016373 D1 DE 602004016373D1 DE 602004016373 T DE602004016373 T DE 602004016373T DE 602004016373 T DE602004016373 T DE 602004016373T DE 602004016373 D1 DE602004016373 D1 DE 602004016373D1
Authority
DE
Germany
Prior art keywords
hydroxysteroid dehydrogenase
dehydrogenase type
new inhibitors
17beta
17beta hydroxysteroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004016373T
Other languages
German (de)
English (en)
Inventor
Josef Messinger
Heinrich-Hubert Thole
Bettina Husen
Steen Bartholomeus Johannes Van
Gyula Schneider
Johannes Bernardus Everardus Hulshof
Pasi Koskimies
Nina Johansson
Jerzy Adamski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Publication of DE602004016373D1 publication Critical patent/DE602004016373D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602004016373T 2003-11-12 2004-11-11 NEUE INHIBITOREN DER 17beta HYDROXYSTEROID-DEHYDROGENASE TYP I Active DE602004016373D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03104169 2003-11-12
EP04105313 2004-10-26
PCT/EP2004/052925 WO2005047303A2 (en) 2003-11-12 2004-11-11 NOVEL 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS

Publications (1)

Publication Number Publication Date
DE602004016373D1 true DE602004016373D1 (de) 2008-10-16

Family

ID=34593637

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004016373T Active DE602004016373D1 (de) 2003-11-12 2004-11-11 NEUE INHIBITOREN DER 17beta HYDROXYSTEROID-DEHYDROGENASE TYP I

Country Status (22)

Country Link
EP (1) EP1685150B1 (xx)
JP (1) JP4778438B2 (xx)
KR (1) KR101070025B1 (xx)
AR (1) AR046580A1 (xx)
AT (1) ATE407139T1 (xx)
AU (1) AU2004289459B2 (xx)
BR (1) BRPI0416551A (xx)
CA (1) CA2545704C (xx)
DE (1) DE602004016373D1 (xx)
DK (1) DK1685150T3 (xx)
ES (1) ES2314478T3 (xx)
HK (1) HK1099309A1 (xx)
HR (1) HRP20080603T3 (xx)
IL (1) IL175220A (xx)
NO (1) NO20062679L (xx)
PL (1) PL1685150T3 (xx)
PT (1) PT1685150E (xx)
RU (1) RU2369614C2 (xx)
SA (1) SA04250373B1 (xx)
SI (1) SI1685150T1 (xx)
TW (1) TWI331154B (xx)
WO (1) WO2005047303A2 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004025985A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
CN102796160A (zh) * 2005-05-26 2012-11-28 索尔瓦药物有限公司 17β-HSD1和STS抑制剂
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
WO2007096647A2 (en) * 2006-02-27 2007-08-30 Sterix Limited Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
RU2469042C2 (ru) * 2006-09-19 2012-12-10 Зольвай Фармасьютиклз Гмбх Терапевтически активные триазолы и их использование
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
CN101568547B (zh) * 2006-11-30 2014-06-25 索尔瓦药物有限公司 作为17βHSD抑制剂的被取代的雌三烯衍生物
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
DE102007015169A1 (de) 2007-03-27 2008-10-02 Universität des Saarlandes Campus Saarbrücken 17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
DE102007040243A1 (de) * 2007-08-25 2009-02-26 Universität des Saarlandes 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
KR20130108586A (ko) 2010-09-23 2013-10-04 애브비 인코포레이티드 아자아다만탄 유도체의 일수화물
EP2688901B1 (en) 2011-03-25 2019-05-08 Université Laval INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
JP6461127B2 (ja) 2013-06-25 2019-01-30 フォレンド ファーマ リミテッド １７βヒドロキシステロイド脱水素酵素、タイプＩの阻害剤としての治療活性エストラトリエンチアゾール誘導体
US9663549B2 (en) * 2013-06-25 2017-05-30 Forendo Pharma Ltd. Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
CN105518017B (zh) 2013-06-25 2020-07-14 佛恩多制药有限公司 治疗活性的作为1型17β-羟基类固醇脱氢酶抑制剂的雌三烯噻唑衍生物
WO2016102776A1 (en) 2014-12-23 2016-06-30 Forendo Pharma Ltd Prodrugs of 17.beta.-hsd1 -inhibitors
JP6545266B2 (ja) * 2014-12-23 2019-07-17 フォレンド ファーマ リミテッド １７β‐ＨＳＤ１抑制剤のプロドラッグ
CZ307437B6 (cs) 2016-06-07 2018-08-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. 15β-substituované deriváty estronu jako selektivní inhibitory 17β-hydroxysteoiddehydrogenáz
DK3634975T3 (da) * 2017-06-08 2024-05-27 Organon R&D Finland Ltd 17-oximer af 15.beta.-[3-propanamido]-substituerede estra-1,3,5(10)-trien-17-oner til anvendelse i inhibition af 17.beta.-hydroxysteroid-dehydrogenaser
EP3891167A1 (en) * 2018-12-05 2021-10-13 Forendo Pharma Ltd Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1

Also Published As

Publication number Publication date
RU2006120488A (ru) 2008-01-10
HRP20080603T3 (en) 2009-03-31
SI1685150T1 (sl) 2008-12-31
IL175220A (en) 2010-12-30
NO20062679L (no) 2006-08-10
AU2004289459B2 (en) 2010-08-19
AR046580A1 (es) 2005-12-14
EP1685150B1 (en) 2008-09-03
AU2004289459A1 (en) 2005-05-26
ES2314478T3 (es) 2009-03-16
TW200521133A (en) 2005-07-01
TWI331154B (en) 2010-10-01
KR101070025B1 (ko) 2011-10-04
SA04250373B1 (ar) 2009-12-22
HK1099309A1 (en) 2007-08-10
JP4778438B2 (ja) 2011-09-21
PT1685150E (pt) 2008-11-12
DK1685150T3 (da) 2008-12-01
WO2005047303A2 (en) 2005-05-26
BRPI0416551A (pt) 2007-02-27
JP2007510697A (ja) 2007-04-26
RU2369614C2 (ru) 2009-10-10
WO2005047303A3 (en) 2005-08-25
ATE407139T1 (de) 2008-09-15
PL1685150T3 (pl) 2009-02-27
IL175220A0 (en) 2006-09-05
EP1685150A2 (en) 2006-08-02
CA2545704A1 (en) 2005-05-26
CA2545704C (en) 2012-06-26
KR20060121171A (ko) 2006-11-28
SA04250373A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
ATE407139T1 (de) Neue inhibitoren der 17beta hydroxysteroid- dehydrogenase typ i
DE602005011795D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
DK1789041T3 (da) Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
DK1797042T3 (da) Indozolonderivater som 11B-HSD1-inhibitorer
ATE452631T1 (de) N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer
DE602005001074D1 (de) Wässerige Beschichtungszusammensetzung
DK2039685T3 (da) Heterobicycliske forbindelser som P38-inhibitorer
DE602005014646D1 (de) Substituierte propenylpiperazinderivate als neue inhibitoren von histondeacetylase
DK1709125T3 (da) Overtrækssammensætning med overfladerensende egenskaber
DK1664043T3 (da) Sammensætninger egnede som inhibitorer af proteinkinaser
DK1713806T3 (da) Forbindelser og sammensætninger som proteinkinaseinhibitorer
ATE401893T1 (de) Thiophenepyrimidinone als 17-beta-hydroxysteroid dehydrogenase inhibitoren
DE602004010873D1 (de) Phasenaustauschtintenzusammensetzungen
DK1763517T3 (da) Pyrimidinderivater som 11beta-HSD1-inhibitorer
ATE545642T1 (de) Mmp-inhibitoren
DK1817387T3 (da) Anvendelse af polysilazaner til belægning af metalbånd
DE112005003431A5 (de) Neuartige Inhibitoren der Lysyloxidase
DK1536796T3 (da) N-arylpiperidinsubstituerede biphenylcarboxamider som inhibitorer af apolipoprotein B-sektion
DE602004018936D1 (de) Härtbare zusammensetzung
DE602005009803D1 (de) N von schutztinte
NO20034109D0 (no) Parafininhibitor-komposisjon
IS7963A (is) Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa
ITMN20030042A1 (it) Doccetta apri-chiudi
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
DE602004001543D1 (de) Tintenzusammensetzung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition